Buscar
LB Pharmaceuticals Inc
LBRXAñadir a la lista de seguimiento
40.080USD
-0.820-2.00%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.15BCap. mercado
PérdidaP/E TTM
Más Datos de LB Pharmaceuticals Inc Compañía
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.
Información de LB Pharmaceuticals Inc
Símbolo de cotizaciónLBRX
Nombre de la empresaLB Pharmaceuticals Inc
Fecha de salida a bolsaSep 11, 2025
Director ejecutivoTurner (Heather D)
Número de empleados16
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 11
DirecciónOne Pennsylvania Plaza, Suite 1025
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10119
Teléfono19174506581
Sitio Webhttps://lbpharma.us/
Símbolo de cotizaciónLBRX
Fecha de salida a bolsaSep 11, 2025
Director ejecutivoTurner (Heather D)
Ejecutivos de LB Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Zachary Prensky
Mr. Zachary Prensky
Co-Founder, Director
Co-Founder, Director
61.27K
--
Mr. Marc L. Panoff, CPA
Mr. Marc L. Panoff, CPA
Senior Vice President - Finance
Senior Vice President - Finance
10.24K
--
Ms. Heather D. Turner, J.D.
Ms. Heather D. Turner, J.D.
Chief Executive Officer, Member of our Board of Director
Chief Executive Officer, Member of our Board of Director
--
--
Mr. Gad Soffer
Mr. Gad Soffer
Chief Business Officer
Chief Business Officer
--
--
Dr. Anna Eramo, M.D.
Dr. Anna Eramo, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Richard Silva, Ph.D.
Mr. Richard Silva, Ph.D.
Senior Vice President of Technical Operations
Senior Vice President of Technical Operations
--
--
Mr. Scott Garland
Mr. Scott Garland
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Rajul Jain, M.D.
Dr. Rajul Jain, M.D.
Independent Director
Independent Director
--
--
Ms. Rebecca Luse
Ms. Rebecca Luse
Independent Director
Independent Director
--
--
Mr. Ran Nussbaum
Mr. Ran Nussbaum
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Zachary Prensky
Mr. Zachary Prensky
Co-Founder, Director
Co-Founder, Director
61.27K
--
Mr. Marc L. Panoff, CPA
Mr. Marc L. Panoff, CPA
Senior Vice President - Finance
Senior Vice President - Finance
10.24K
--
Ms. Heather D. Turner, J.D.
Ms. Heather D. Turner, J.D.
Chief Executive Officer, Member of our Board of Director
Chief Executive Officer, Member of our Board of Director
--
--
Mr. Gad Soffer
Mr. Gad Soffer
Chief Business Officer
Chief Business Officer
--
--
Dr. Anna Eramo, M.D.
Dr. Anna Eramo, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Richard Silva, Ph.D.
Mr. Richard Silva, Ph.D.
Senior Vice President of Technical Operations
Senior Vice President of Technical Operations
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de LB Pharmaceuticals Inc?
Los cinco principales accionistas de LB Pharmaceuticals Inc son: Mr. Zachary Prensky